[1]
Nawale, R., Pol, S., Puranik, P., Daud, A. and Rajkondawar, V. 2018. ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF DABIGATRAN ETEXILATE RELATED SUBSTANCE IN PHARMACEUTICAL DOSAGE FORM BY REVERSE‑PHASE – HIGH‑PERFORMANCE LIQUID CHROMATOGRAPHY. Asian Journal of Pharmaceutical and Clinical Research. 11, 10 (Oct. 2018), 357–364. DOI:https://doi.org/10.22159/ajpcr.2018.v11i10.27043.